Activation of the A2A adenosine receptor inhibits nitric oxide production in glial cells

FEBS Letters
C BrodieK A Jacobson

Abstract

Selective adenosine receptor agonists and antagonists have marked effects on the outcome of cerebral ischemia, and adenosine receptors are expressed on astrocytes. In this study we examined the effects of various adenosine receptor agonists on the production of nitric oxide and the induction of iNOS in astrocytes activated by LPS/IFN-gamma and TNF-alpha/IL-1beta and on the production of TNF-alpha. Treatment of the cells with the A2A receptor agonist CGS 21680 inhibited both NO production and iNOS expression induced by stimulation with either LPS/IFN-gamma or TNF-alpha/IL-1beta, whereas the A1 and A3 receptor agonists, CPA and Cl-IB-MECA, respectively, did not have significant inhibitory effects. The inhibitory effect of the A2A receptor agonist was antagonized by the specific A2A receptor antagonist CSC. The A2A agonist also exerted a small inhibitory effect on the production of TNF-alpha. Similar inhibitory effects on the production of NO were obtained by cyclic AMP-elevating reagents, such as forskolin and dibutyryl cyclic AMP. Our findings suggest that activation of the A2A receptor inhibits NO production and iNOS expression likely via increased cAMP.

References

Sep 1, 1992·Journal of Neurochemistry·M L Simmons, S Murphy
Jan 1, 1989·Journal of Clinical Immunology·E M FrohmanS Gupta
Nov 1, 1994·Journal of Neuroscience Research·S K Park, S Murphy
Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·D C HooperH Koprowski
Aug 1, 1993·Trends in Neurosciences·S MurphyJ P Schwartz
Sep 22, 1994·European Journal of Pharmacology·D K Von LubitzK A Jacobson
Jan 1, 1994·British Journal of Pharmacology·M C Peakman, S J Hill
Jul 1, 1993·The European Journal of Neuroscience·M L Simmons, S Murphy
Jan 1, 1995·Annual Review of Cell and Developmental Biology·S R Jaffrey, S H Snyder

❮ Previous
Next ❯

Citations

Nov 9, 2000·Journal of Neuroscience Research·T Imura, S Shimohama
Apr 12, 2008·Purinergic Signalling·Maria P Abbracchio, Stefania Ceruti
Mar 26, 2011·Purinergic Signalling·Maria Letizia TrincavelliClaudia Martini
Mar 14, 2009·Molecular Neurobiology·Alexei VerkhratskyGeoffrey Burnstock
Feb 7, 2013·Neurochemistry International·Eleonora AronicaDetlev Boison
Feb 13, 1999·European Journal of Pharmacology·D K Von Lubitz
Jun 4, 1999·European Journal of Pharmacology·D K von Lubitz
Sep 19, 2009·Cell Death and Differentiation·D BoisonB B Fredholm
Jul 4, 2001·Journal of Neurochemistry·D DassesseS N Schiffmann
Apr 3, 2001·Expert Opinion on Investigational Drugs·D K von Lubitz
Jan 5, 2000·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·R GregersenB Finsen
Aug 12, 2005·Journal of Neurochemistry·Josep SauraJoan Serratosa
Aug 29, 2014·Mediators of Inflammation·Felicita PedataAlessia Melani
Mar 2, 2005·Pharmacology & Therapeutics·Kui XuMichael Schwarzschild
Nov 17, 2004·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Leslie Thomas Buck
Jun 30, 2006·Journal of the Neurological Sciences·Anti KaldaJiang-Fan Chen
Nov 9, 2019·Behavioural Pharmacology·Lais S RodriguesMarcelo M S Lima
Jun 21, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Natalia PalaciosAlberto A Ascherio
Jul 2, 2016·Journal of Neurochemistry·Rodrigo A Cunha
May 19, 2018·Therapeutic Advances in Neurological Disorders·Abraham MartínCarlos Matute
Mar 21, 2020·Journal of the Neurological Sciences·Meiying XinDi Ma
Aug 14, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Cristiane MaiaRafael Rodrigues Lima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.